3 Pot Stocks Poised for Epic Growth

When you invest in The Green Organic Dutchman Holdings Ltd. (TSX:TGOD), The Flowr Corp. (TSXV:FLWR) or Auxly Cannabis Group Inc. (TSXV:XLY), be patient. All three companies will soon deliver monumental returns.

| More on:

The legalization of adult-use marijuana in Canada is almost one-year-old. Will pot stocks ever deliver sky-high returns? Believe it or not, The Green Organic Dutchman (TSX:TGOD), Flowr (TSXV:FLWR), and Auxly (TSXV:XLY) will carry the torch for the industry. All three pot stocks are poised for epic growth.

Purely organic

TGOD was built on the concept of entirely organic processes. All of its products are free of synthetic pesticides and fertilizers. Led by CEO Brian Athaide, the company will make sure TGOD would be able to provide organic cannabis on an international scale.

Athaide brings with him more than 28 years of global executive experience. Before joining TGOD, Athaide held top-level positions at Andrew Peller and Proctor & Gamble.

With a projected peak annual production of 219,000 kilograms, TGOD would be one of Canada’s top five cannabis producers. Once the facilities are fully operational, its $39.1 million sales in 2019 could surge to $227.9 million, or a monstrous 482.9% increase.

TGOD’s flagship Valleyfield campus will concentrate on beverage and edible production. A three-year agreement with extraction services provider Neptune Wellness Solutions is in place.

TGOD can ramp up commercial production of high-margin derivative products from 200,000 plus kilos of cannabis and hemp biomass. TGOD would finally taste profitability for the first time in 2020.

Blossoming flower

Flowr is not a significant cannabis grower, but the small-cap stock offers tremendous growth opportunities. Its flagship Kelowna facility, one of the most advanced, purpose-built cultivation facilities in the world, could produce a minimum of 50,000 kilos at peak capacity.

With its niche play on dried flowers (premium and ultra-premium) and derivatives, the company won’t be dealing with pricing or supply issues. Sales in 2019 could potentially skyrocket by 354.8% to $104.6 million in 2020.

Flowr’s seven million square feet grow farm in Portugal would create derivative products for Europe’s medical market. Once fully operational, the outdoor growing facility could produce half-a-million kilos of marijuana.

But the Kelowna campus is Flowr’s most significant advantage. The facility could grow varieties of top quality cannabis cycle after cycle and with consistency.

Cheapest but astonishing potential

You can buy Auxly for less than $1 today, but don’t underestimate this $554.95 million integrated cannabis company. Your investment could grow by 3,077.5% in a year.

A team composed of visionaries with in-depth industry knowledge formed Auxly in 2017. The members possess the scientific and technical expertise to bring branded and high-quality cannabis products to the medical, wellness and adult-use markets.

Auxly could be the fastest-growing cannabis stock because of several streaming partnerships and the joint venture with Sunens Farms. Sunens is a fully automated, purpose-built greenhouse that’s currently under construction. Bank of Montreal is providing a $71.5 syndicated credit facility.

The one million square feet greenhouse can cultivate 100,000 kilograms of cannabis yearly beginning the second quarter of 2020. Auxly earned a paltry $5.8 million in 2019 because the joint venture and the partnerships have yet to obtain the cultivation licenses.

By next year, however, you can expect Auxly’s sales to balloon to $184.3 million. The company is holding back dried flower production. The plan is to transform this low-margin product into high-margin derivatives (concentrates, edibles, and vapes) and make them the future growth drivers.

Not dead in the water

The cannabis industry is not dead in the water. The three small-cap pot stocks would prove critics wrong with epic growth in 2020 and beyond.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool is short shares of Procter & Gamble.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »